Comparison Among Erythropoietin Stimulating Agents

Clinical trial NCT02049346 · COMPLETED

Trial details

NCT number: NCT02049346
Sponsor: Hamad Medical Corporation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Anemia of End Stage Renal Disease

Start date: 2012-03-01
Primary completion: 2013-04-01
Enrollment: 327

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.